Polaková Eva, Veselka Josef
Department of Cardiology, Second Medical School, Charles University, Motol University Hospital, Prague, Czech Republic.
Int J Angiol. 2022 Sep 23;31(3):194-197. doi: 10.1055/s-0042-1756176. eCollection 2022 Sep.
Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism.
肺栓塞是静脉血栓栓塞性疾病的一种潜在致命表现。它是发达国家心血管发病和死亡的三大主要原因之一。多年来,实施了更好的诊断和风险分层措施。一系列新的治疗选择不断涌现,特别是在大面积肺栓塞的治疗方面。尽管如此,由于现有治疗选择缺乏科学依据,临床医生在临床实践中常常面临不确定性。本文旨在综述大面积肺栓塞的治疗。